ARCHIVES

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 20 | May 22, 2009

Download PDF Visit The Full Archive

Related Articles

New Phone Number For Customer Service For The Cancer Letter

February 6, 1998

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

NCAB Approves Characteristics for Recognition As Comprehensive; Outlook Dim for New Division

May 19, 1989

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Fruit, Candy Flavored Cigarettes Banned In U.S.; FDA To Examine Menthol Flavored Tobacco

September 25, 2009